Radek Ampapa

2.2k total citations
10 papers, 51 citations indexed

About

Radek Ampapa is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Radek Ampapa has authored 10 papers receiving a total of 51 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 2 papers in Oncology. Recurrent topics in Radek Ampapa's work include Multiple Sclerosis Research Studies (7 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Radek Ampapa is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Radek Ampapa collaborates with scholars based in Czechia, Slovakia and United States. Radek Ampapa's co-authors include Marta Vachová, Martin Vališ, Dana Horáková, Ivana Štětkářová, Jana Nováková, Pavel Štourač, Karel Holada, Pavel Hradílek, Robert Rusina and Jan Mareš and has published in prestigious journals such as Neurology, International Journal of Molecular Sciences and Frontiers in Neurology.

In The Last Decade

Radek Ampapa

9 papers receiving 48 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radek Ampapa Czechia 4 32 17 14 11 7 10 51
Fatemeh Afrashteh Iran 4 22 0.7× 10 0.6× 7 0.5× 5 0.5× 2 0.3× 12 42
Michael Waltz United States 3 31 1.0× 8 0.5× 3 0.2× 4 0.4× 4 0.6× 6 51
Ali Forouhari Iran 5 28 0.9× 4 0.2× 4 0.3× 5 0.5× 4 0.6× 8 57
E. Hennes Austria 3 14 0.4× 17 1.0× 9 0.6× 5 0.5× 1 0.1× 4 42
Adrian Pace United Kingdom 3 11 0.3× 8 0.5× 7 0.5× 9 0.8× 10 1.4× 5 36
Victor M. Orellana‐Noia United States 4 21 0.7× 10 0.6× 7 0.5× 4 0.4× 6 0.9× 13 34
Yinshui Chang Germany 4 12 0.4× 3 0.2× 7 0.5× 6 0.5× 2 0.3× 5 35
Marek Śmiłowski Poland 4 8 0.3× 25 1.5× 4 0.3× 3 0.3× 1 0.1× 10 39
Lutz Achtnichts Switzerland 3 34 1.1× 17 1.0× 33 2.4× 4 0.4× 1 0.1× 5 45
Guimei Li China 3 4 0.1× 21 1.2× 31 2.2× 23 2.1× 6 0.9× 5 68

Countries citing papers authored by Radek Ampapa

Since Specialization
Citations

This map shows the geographic impact of Radek Ampapa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radek Ampapa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radek Ampapa more than expected).

Fields of papers citing papers by Radek Ampapa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radek Ampapa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radek Ampapa. The network helps show where Radek Ampapa may publish in the future.

Co-authorship network of co-authors of Radek Ampapa

This figure shows the co-authorship network connecting the top 25 collaborators of Radek Ampapa. A scholar is included among the top collaborators of Radek Ampapa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radek Ampapa. Radek Ampapa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kancheva, Radmila, Martin Hill, Marta Velíková, et al.. (2024). Altered Steroidome in Women with Multiple Sclerosis. International Journal of Molecular Sciences. 25(22). 12033–12033. 2 indexed citations
2.
Vališ, Martin, Michal Novotný, Blanka Klímová, et al.. (2022). Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry. Frontiers in Neurology. 13. 851426–851426. 3 indexed citations
3.
Ampapa, Radek. (2022). Cognitive dysfunction in secondary progressive multiple sclerosis. Neurologie pro praxi. 23(3). 221–226.
4.
Hradílek, Pavel, Eva Meluzínová, Olga Zapletalová, et al.. (2021). Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic. Multiple Sclerosis and Related Disorders. 59. 103391–103391. 4 indexed citations
5.
Ampapa, Radek, et al.. (2021). Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia. Multiple Sclerosis and Related Disorders. 54. 103104–103104. 22 indexed citations
6.
Sobíšek, Lukáš, Ivana Štětkářová, Pavel Štourač, et al.. (2021). Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS. Frontiers in Neurology. 11. 593527–593527. 3 indexed citations
7.
Horáková, Dana, Marta Vachová, Jan Mareš, et al.. (2021). Oral cladribine in the treatment of multiple sclerosis – data from the national registry ReMuS® registry. Česká a slovenská neurologie a neurochirurgie. 84/117(6). 1 indexed citations
8.
Horáková, Dana, Tomáš Doležal, Marta Vachová, et al.. (2019). Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS. Multiple Sclerosis and Related Disorders. 35. 196–202. 5 indexed citations
9.
Cadavid, Diego, Alexander Klistorner, Radek Ampapa, et al.. (2016). Correlation of Physical, Cognitive and MRI Measures with Multifocal Visual Evoked Potential using Baseline Data from the Anti-LINGO-1 SYNERGY Trial in Multiple Sclerosis (P3.041). Neurology. 86(16_supplement). 2 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatemeh Afrashteh Breakdown of academic impact, for papers by Michael Waltz Breakdown of academic impact, for papers by Ali Forouhari Breakdown of academic impact, for papers by E. Hennes Breakdown of academic impact, for papers by Adrian Pace Breakdown of academic impact, for papers by Victor M. Orellana‐Noia Breakdown of academic impact, for papers by Yinshui Chang Breakdown of academic impact, for papers by Marek Śmiłowski Breakdown of academic impact, for papers by Lutz Achtnichts Breakdown of academic impact, for papers by Guimei Li
Rankless by CCL
2026